Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HK.20.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.5.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.13.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JY.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCREWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.86EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.1.2.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GE.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FU.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.86.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JG.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JR.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.1.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.20.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.110EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.86.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GN.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.8.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.89EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HP.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCF.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JC.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.105EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.9.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.106EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FE.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FT.3.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used